CD4 and neoplasm: Moreover, a subset of CD4+ T lymphocytes may sustain the primary infection of B lymphocytes or even induce the expansion of tumor B cells mainly through IL-4 and IL-13 release and CD40 engagement, as demonstrated in vitro (183) and in vivo in hu/SCID mouse models (184).